Clinical trial

Molecular Imaging of Prostate-Specific Membrane Antigen Using Labeled Technetium-99m BQ0413

NCT06101927

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2023-10-19

PhasePHASE1

Study timeline

Study start (actual)2023-10-19Date precision: day

Registry last updated2026-06-24

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Prostate Cancerunresolved

Interventions

Whole body study and SPECT with [99mTc]Tc-BQ0413DRUG

Sponsors & collaborators

Tomsk National Research Medical Center of the Russian Academy of Scienceslead sponsor

Uppsala Universitycollaborator

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT06101927 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.